Nervosave Therapeutics

Nervosave Therapeutics is developing a platform of local gene therapies that slow, stop and reverse a broad range of diseases involving peripheral nerves.

Their first aim is to develop best in class gene therapy for CMT1A and then beyond for all CMT diseases.

Their platform has game-changing potential in several devastating diseases with clear therapeutic needs such as neuralgias, diabetic peripheral neuropathy and other degenerative diseases involving nerves.